MANKIND2023-10-012023-12-31 MANKIND2023-10-012023-12-31 MANKIND2023-10-012023-12-31in-bse-fin:OneOperatingExpenses01Member MANKIND2023-10-012023-12-31in-bse-fin:FourOperatingExpenses01Member MANKIND2023-12-31 MANKIND2023-10-012023-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member MANKIND2023-10-012023-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member MANKIND2023-10-012023-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss03Member MANKIND2023-10-012023-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member MANKIND2023-10-012023-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss02Member MANKIND2023-10-012023-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss03Member MANKIND2023-10-012023-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member MANKIND2023-10-012023-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 543904 MANKIND NOTLISTED Mankind Pharma Limited Equity 2023-04-01 2024-03-31 2024-01-31 2024-01-16 INR Lakhs Third quarter 15:55:00 17:10:00 2024-01-31 2024-01-31 Not applicable Single segment Pharmaceuticals 2023-10-01 2023-12-31 Unaudited Consolidated 26069589000.00 701326000.00 26770915000.00 4567436000.00 3527929000.00 180528000.00 5683527000.00 91854000.00 1097266000.00 6045107000.00 21193647000.00 5577268000.00 0.00 5577268000.00 712048000.00 313107000.00 1025155000.00 0.00 4552113000.00 0.00 0.00 0.00 46024000.00 4598137000.00 57523000.00 4655660000.00 4537600000.00 60537000.00 4594712000.00 60948000.00 400588000.00 1 11.33 11.31 0.00 0.00 11.33 11.31 Due to limitation of characters in xbrl utility, we are facing constraints to disclose all notes to accounts. Kindly refer PDF version of financials results uploaded on the Stock Exchanges website: www.bseindia.com and www.nseindia.com and also on the Company’s website: www.mankindpharma.com. Single segment 2023-04-01 2023-12-31 Unaudited Consolidated 78936754000.00 1887299000.00 80824053000.00 14171743000.00 10675654000.00 -123323000.00 16932215000.00 241494000.00 2935660000.00 17840786000.00 62674229000.00 18149824000.00 0.00 18149824000.00 3780627000.00 -154597000.00 3626030000.00 0.00 14523794000.00 0.00 0.00 0.00 127994000.00 14651788000.00 3391000.00 14655179000.00 14416582000.00 235206000.00 14418738000.00 236441000.00 400588000.00 1 35.99 35.94 0.00 0.00 35.99 35.94 Other expenses 6045107000.00 Other expenses 17840786000.00 Re-measurement losses on defined benefit plans -22177000.00 Share of other comprehensive income/ (loss) of associates and joint ventures 320000.00 Change in the fair value of equity investments at FVTOCI 110785000.00 Re-measurement losses on defined benefit plans -115235000.00 Share of other comprehensive income/ (loss) of associates and joint ventures 486000.00 Change in the fair value of equity investments at FVTOCI 112609000.00 88928000.00 -2140000.00 17726000.00 -14594000.00 Exchange differences in translating the financial statements of foreignnoperations -13679000.00 Exchange differences in translating the financial statements of foreignnoperations -9063000.00 -13679000.00 -9063000.00 0.00 0.00